Form 8-K

Send us Feedback

Biogen Idec (BIIB)

	SUMMARY

	BULLS

	BEARS

	TOPICS

	DATA CENTRAL

	STOCK CHART

	SEC FILINGS

	BALANCE

	INCOME

	CASH FLOW

Annual Reports

Quarterly Reports

8-K

8-K (Oct 25, 2012)8-K (Oct 9, 2012)8-K (Jul 24, 2012)8-K (Jun 13, 2012)8-K (May 1, 2012)8-K (Mar 2, 2012)8-K (Jan 31, 2012)8-K (Dec 19, 2011)8-K (Dec 14, 2011)8-K (Nov 29, 2011)8-K (Oct 28, 2011)8-K (Sep 29, 2011)8-K (Jul 26, 2011)8-K (Jun 24, 2011)8-K (Jun 23, 2011)8-K (Jun 7, 2011)8-K (Apr 21, 2011)8-K (Mar 1, 2011)8-K (Feb 11, 2011)8-K (Feb 1, 2011)8-K (Jan 21, 2011)8-K (Nov 3, 2010)8-K (Oct 26, 2010)8-K (Oct 21, 2010)8-K (Oct 8, 2010)8-K (Aug 6, 2010)8-K (Jul 20, 2010)8-K (Jul 1, 2010)8-K (Jun 10, 2010)8-K (Jun 7, 2010)8-K (Apr 20, 2010)8-K (Mar 22, 2010)8-K (Feb 9, 2010)8-K (Jan 28, 2010)8-K (Jan 12, 2010)8-K (Jan 4, 2010)8-K (Dec 10, 2009)8-K (Oct 20, 2009)8-K (Sep 15, 2009)8-K (Sep 4, 2009)8-K (Aug 26, 2009)8-K (Jul 16, 2009)8-K (May 4, 2009)8-K (Apr 16, 2009)8-K (Mar 30, 2009)8-K (Mar 12, 2009)8-K (Feb 6, 2009)8-K (Jan 16, 2009)8-K (Jan 13, 2009)8-K (Jan 9, 2009)8-K (Dec 15, 2008)8-K (Oct 29, 2008)8-K (Oct 21, 2008)8-K (Oct 17, 2008)8-K (Aug 1, 2008)8-K (Jul 31, 2008)8-K (Jul 24, 2008)8-K (Jul 22, 2008)8-K (Jul 9, 2008)8-K (May 30, 2008)8-K (May 29, 2008)8-K (Apr 23, 2008)8-K (Mar 4, 2008)8-K (Feb 27, 2008)8-K (Feb 15, 2008)8-K (Feb 6, 2008)8-K (Jan 28, 2008)8-K (Jan 11, 2008)8-K (Jan 7, 2008)8-K (Dec 21, 2007)8-K (Oct 23, 2007)8-K (Sep 6, 2007)8-K (Aug 28, 2007)8-K (Aug 13, 2007)8-K (Jul 24, 2007)8-K (Jul 2, 2007)8-K (Jun 29, 2007)8-K (Jun 18, 2007)8-K (May 30, 2007)8-K (May 2, 2007)8-K (Feb 15, 2007)8-K (Dec 18, 2006)8-K (Dec 12, 2006)8-K (Oct 31, 2006)8-K (Jul 26, 2006)8-K (Jul 14, 2006)8-K (May 26, 2006)8-K (Apr 26, 2006)8-K (Apr 10, 2006)8-K (Mar 9, 2006)8-K (Mar 6, 2006)8-K (Feb 15, 2006)8-K (Feb 10, 2006)8-K (Dec 22, 2005)8-K (Dec 12, 2005)8-K (Nov 14, 2005)8-K (Oct 26, 2005)8-K (Oct 3, 2005)8-K (Sep 15, 2005)8-K (Sep 13, 2005)8-K (Aug 11, 2005)8-K (Jul 26, 2005)8-K (Jun 16, 2005)8-K (Jun 6, 2005)8-K (May 11, 2005)8-K (May 3, 2005)8-K (Apr 27, 2005)8-K (Apr 1, 2005)8-K (Mar 23, 2005)8-K (Mar 17, 2005)8-K (Mar 7, 2005)8-K (Mar 3, 2005)8-K (Feb 24, 2005)8-K (Feb 22, 2005)8-K (Feb 7, 2005)8-K (Jan 6, 2005)8-K (Dec 20, 2004)8-K (Dec 15, 2004)8-K (Dec 1, 2004)8-K (Nov 30, 2004)8-K (Nov 5, 2004)8-K (Oct 27, 2004)8-K (Sep 29, 2004)8-K (Sep 22, 2004)8-K (Jul 28, 2004)8-K (Jul 23, 2004)8-K (Jun 4, 2004)8-K (Apr 30, 2004)8-K (Apr 14, 2004)8-K (Mar 25, 2004)8-K (Mar 4, 2004)8-K (Feb 19, 2004)8-K (Feb 13, 2004)8-K (Jan 12, 2004)8-K (Nov 25, 2003)8-K (Nov 21, 2003)8-K (Nov 12, 2003)8-K (Oct 14, 2003)8-K (Oct 3, 2003)8-K (Sep 3, 2003)8-K (Jul 31, 2003)8-K (Jul 17, 2003)8-K (Jun 23, 2003)8-K (Apr 15, 2003)

Other

Biogen Idec 8-K 2012

Documents found in this filing:

Form 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of The

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): January 31, 2012

Biogen Idec Inc.

(Exact name of registrant as specified in its charter)


Delaware	0-19311	33-0112644
(State or other jurisdiction of incorporation)	(Commission file number)	(IRS Employer Identification No.)

133 Boston Post Road, Weston, Massachusetts		02493
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: (781) 464-2000

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

¨	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 2.02

Results of Operations and Financial Condition.

On January 31, 2012, Biogen Idec Inc. issued a press release announcing its results of operations and financial condition for the full year and three months ended December 31, 2011. A copy of the press release is furnished as Exhibit 99 and is incorporated herein by reference.

The press release is being furnished pursuant to Item 2.02 of this Current Report on Form 8-K and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that Section, nor shall such document be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act.

Item 9.01

Financial Statements and Exhibits.

The exhibits listed on the Exhibit Index immediately preceding such exhibits are furnished as part of this Current Report on Form 8-K.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


Biogen Idec Inc.

By:		/s/ Susan H. Alexander
		Susan H. Alexander
		Executive Vice President and General Counsel

Date: January 31, 2012

EXHIBIT INDEX


Exhibit Number		Description

99		Biogen Idec’s press release dated January 31, 2012.

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.

Mobile | Advertise | Licensing & Partnerships | Blogger Tools | Jobs

Biogen Idec (BIIB)

Annual Reports

Quarterly Reports

8-K

Other

Documents found in this filing: